Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin vs Ceftriaxone for ERCP Prophylaxis
NCT02098486Phase 2Completed
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Mar 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of moxifloxacin in cholangitis, sponsored by Kangbuk Samsung Hospital. Started Mar 2014; status: completed.
02
Drugs
moxifloxacin
03
Conditions
cholangitis
Beyond the preview
Go deeper on NCT02098486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098486.